Otsuka has dumped a clutch of clinical cancer candidates on Valentine's day. | Otsuka has broken up with a clutch of clinical ...
This study presents solid evidence for distinct neurotransmitter release modalities between two subclasses of dopaminergic neurons in the olfactory bulb, highlighting an important finding that ...
Apollo Silver Corp. ("Apollo Silver" or the "Company") is pleased to provide details on the upcoming 2025 work program (the "2025 Program") at its Calico Silver Project ("Calico" or the "Project") ...
In this study, we described the use of KCC2, a neuronal-specific potassium–chloride cotransporter ... 632496), anti-NeuN (Merck Millipore; MAB377), and anti-Gad67 (Merck Millipore, MAB5406). After ...
At the end of the survival period, the animals were euthanized with a sodium pentobarbital overdose and then perfused transcardially with 100 ml of fresh Ringer calcium-free buffer (NaCl, 145.45 mM; ...
Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at Leerink Partners believe that Merck’s Winrevair “should have ...
Merck MRK will report its fourth-quarter and full-year 2024 earnings on Feb. 4, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $15.56 billion and $1.72 per ...
On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...
Greatwall, a conserved MAST-like kinase with crucial mitotic entry functions, is curiously absent in worms. Here, the single ...
Now there’s a new one for the list: cancer prevention vaccines. Merck, which makes the commonly used Gardasil shot, has shed 14 per cent of its market value since announcing last week that it ...
RAHWAY, N.J., January 28, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly ...